You are currently viewing a new version of our website. To view the old version click .

Printed Pharmaceuticals in Future Healthcare

This special issue belongs to the section “Pharmaceutical Technology, Manufacturing and Devices“.

Special Issue Information

Dear Colleagues,

3D printing technologies have rapidly shown their great potential in revolutionizing conventional procedures in pharmaceutical manufacturing, which helps to conceive various patient-centric approaches in a dynamic healthcare environment.  The operating principles of these technologies are key in the development of novel and more flexible drug delivery systems. Thus, different methods, materials, and structural properties of these formulations need to be considered. Furthermore, we need to explore new approaches to introducing these systems into distributed points-of-care, in order to succeed with on-site and safe production and delivery to the patient. In this context, the recent trends in coupling 3D printing with state-of-the-art manufacturing technologies and digital tools can facilitate the optimization of pharmaceutical products, as well as the integration of cross-communication platforms between all involved parties, including the patient, the manufacturing hub, and the healthcare professional.

This Special Issue will cover all aspects of 3D printing strategies for fabricating novel drug delivery systems and future directions for utilizing state-of-the-art technologies, in our quest to improve patients’ well-being in the forthcoming era of a personalized healthcare environment.

Dr. Georgios Eleftheriadis
Dr. Eleftherios G. Andriotis
Prof. Dr. Dimitrios G. Fatouros
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • 3D printing
  • formulations and drug delivery systems
  • personalized treatments
  • future healthcare
  • digital technologies
  • distributed manufacturing

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Published Papers

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Pharmaceutics - ISSN 1999-4923